Intriguingly, our analysis unveiled a significant correlation between a high CDC42 expression in tumor tissues and increased mortality rates in TNBC patients compared to all breast cancer patients (Figure S6 and Figure 6D). Here, CDC42 is linked to breast carcinoma.